open-label metformin

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Non-Insulin-DependentType 2 DiabetesType 2 Diabetes Mellitus, Non Insulin Dependent

Phase 3

A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

CompletedNCT00701090

Merck Sharp & Dohme LLCDiabetes Mellitus, Non-Insulin-Dependent, Type 2 Diabetes Mellitus, Non Insulin Dependent

Start: 2008-05-31End: 2009-10-31Updated: 2017-03-10

Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)

CompletedNCT01841697

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2013-06-13End: 2014-11-17Updated: 2018-09-10

Related Papers

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.

2017-05-1516 citations

Comparison of treatment with sitagliptin or sulfonylurea in patients with type 2 diabetes mellitus and mild renal impairment: a post hoc analysis of clinical trials.

2015-01-307 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial.

2011-02-01115 citations